#ascogi22 Great presentation by Augusto Villanueva @augustoNYC and many others on primary liver cancer. Practice Changing results from TOPAZ-1 in #BiliaryTractCancer and HIMALAYA #HCC later today.
Outstanding work by Dr. Czauderna highlighting the importance of early epigenetic alterations in HCC. Thanks to everybody for the great contribution @jaboeje@ColmJJORourke https://t.co/NHOJO4dxKC
#News: The @EU_Commission has granted approval for a new treatment for adults with locally advanced or metastatic #cholangiocarcinoma with FGFR2 fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
I will be a participant at Digital #LiverCancerSummit 2021. Join me there to discuss the latest knowledge on #livercancer. Together we are stronger against liver cancer. Find out more about the event: https://t.co/8glWYrzbDj @EASLnews